Please wait...
About This Project
The etiological agent for Chagas' disease is the protozoan parasite Trypanosoma cruzi, which affects 6 - 7 million people primarily in Latin America. The chronic stage of infection causes cardiomyopathy and the enlargement of other organs resulting in disease burden and death. There is an urgent need to replace the clinical therapeutics (benznidazole & nifurtimox) and this proposal focuses on a compound screen to observe a hit expansion with the target T. cruzi glucokinase.
More Lab Notes From This Project
Browse Other Projects on Experiment
Related Projects
Developing a low-cost, rapid diagnostic for urogenital Schistosomiasis infection
We are developing a frugal diagnostic for urogenital schistosomiasis, a neglected tropical disease that...
Gila monster genomics: conservation, venom, and treatments for Type-II diabetes
The Gila monster, with its distinctive black and orange pattern, is one of Arizona’s most iconic animals...
Modeling Zika virus transmission from mother to child using uterine mini-organs
As of mid-2019, 87 countries have had or still have Zika cases, underlining the importance of this infectious...